(Q40120649)

17 September 2017

Androgen receptor attenuation of Ad5 replication: implications for the development of conditionally replication competent adenoviruses (English)

1 reference

17 September 2017

1 reference

Wasim H Chowdhury

4

0 references

author name string

Naseruddin Höti

1

1 reference

17 September 2017

Ying Li

2

1 reference

17 September 2017

Chien-Lun Chen

3

1 reference

17 September 2017

David C Johns

5

1 reference

17 September 2017

Qinghua Xia

6

1 reference

17 September 2017

Arup Kabul

7

1 reference

17 September 2017

Jer-Tsong Hsieh

8

1 reference

17 September 2017

Michael Berg

9

1 reference

17 September 2017

Gary Ketner

10

1 reference

17 September 2017

Shawn E Lupold

11

1 reference

17 September 2017

Ronald Rodriguez

12

1 reference

17 September 2017

12 June 2007

1 reference

17 September 2017

1 reference

17 September 2017

15

1 reference

17 September 2017

1495-1503

1 reference

17 September 2017

8

1 reference

Molecular determinants of resistance to antiandrogen therapy

17 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Viral oncoprotein binding to pRB, p107, p130, and p300.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Adenovirus-5 E1A: paradox and paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Role of CBP/P300 in nuclear receptor signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

CREB-binding protein in androgen receptor-mediated signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

A novel method for the determination of basal gene expression of tissue-specific promoters: an analysis of prostate-specific promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

A noncommercial dual luciferase enzyme assay system for reporter gene analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Inducible genetic suppression of neuronal excitability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Reappraisal of the Role of Heat Shock Proteins as Regulators of Steroid Receptor Activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300223

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300223

1 reference

17 September 2017

1 reference